Bio-rad Laboratories, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NYSE
Norman D. Schwartz consolidates significant beneficial ownership of Bio-Rad Laboratories Class B Common Stock following the passing of Alice N. Schwartz, maintaining family control.
NYSE
Norman D. Schwartz has consolidated beneficial ownership and control over Bio-Rad Laboratories' Class A and Class B Common Stock following the passing of Alice N. Schwartz.
NYSE
Norman D. Schwartz consolidates control of Bio-Rad Laboratories' Class B Common Stock following the death of Alice N. Schwartz, becoming the sole trustee of key family trusts.
NYSE
Norman D. Schwartz assumes sole trustee roles for significant Bio-Rad Laboratories, Inc. Class A Common Stock trusts following the passing of Alice N. Schwartz, consolidating family control.
NYSE
An amended Schedule 13D filing reveals Alice N. Schwartz and her revocable trust continue to hold substantial Class A and Class B common stock, solidifying family control over Bio-Rad Laboratories, primarily for estate planning purposes.